The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer

被引：11

作者：

Alonso, Salvador ^{[1
]}

Saltz, Leonard ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[2] Weill Cornell Med, Dept Med, New York, NY USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / 02期

关键词：

METASTATIC COLORECTAL-CANCER; OXALIPLATIN-BASED CHEMOTHERAPY; FLUOROURACIL PLUS LEUCOVORIN; MISMATCH REPAIR STATUS; STAGE-II; ADJUVANT CHEMOTHERAPY; PHASE-III; 1ST-LINE TREATMENT; THERAPY; SURVIVAL;

D O I：

10.1245/s10434-020-09375-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Micrometastatic disease that is present at the time of surgery is responsible for the overwhelming majority of deaths in patients with what is otherwise perceived to be local and regional colon cancer. The goal of perioperative therapy is to eliminate microscopic residual disease that would otherwise be left behind following surgery. A secondary goal specific to neoadjuvant (preoperative) therapy is to downstage tumors deemed potentially not amenable to an R0 resection on the basis of a suspected T4b primary (locally invading into a surrounding structure). In this landmark series paper, we review the current standard for perioperative therapy in patients with colon cancer.

引用

页码：995 / 1001

页数：7

共 41 条

[31] Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer [J].

Sargent, Daniel J. ;

Marsoni, Silvia ;

Monges, Genevieve ;

Thibodeau, Stephen N. ;

Labianca, Roberto ;

Hamilton, Stanley R. ;

French, Amy J. ;

Kabat, Brian ;

Foster, Nathan R. ;

Torri, Valter ;

Ribic, Christine ;

Grothey, Axel ;

Moore, Malcolm ;

Zaniboni, Alberto ;

Seitz, Jean-Francois ;

Sinicrope, Frank ;

Gallinger, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3219-3226

[32] Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial [J].

Schmoll, Hans-Joachim ;

Tabernero, Josep ;

Maroun, Jean ;

de Braud, Filippo ;

Price, Timothy ;

Van Cutsem, Eric ;

Hill, Mark ;

Hoersch, Silke ;

Rittweger, Karen ;

Haller, Daniel G. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) :3733-+

[33] DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy [J].

Sinicrope, Frank A. ;

Foster, Nathan R. ;

Thibodeau, Stephen N. ;

Marsoni, Silvia ;

Monges, Genevieve ;

Labianca, Roberto ;

Yothers, Greg ;

Allegra, Carmen ;

Moore, Malcolm J. ;

Gallinger, Steven ;

Sargent, Daniel J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (11) :863-875

[34]

Sobrero AF, 2020, J CLIN ONCOL, V38

[35] Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial [J].

Taieb, Julien ;

Zaanan, Aziz ;

Le Malicot, Karine ;

Julie, Catherine ;

Blons, Helene ;

Mineur, Laurent ;

Bennouna, Jaafar ;

Tabernero, Josep ;

Mini, Enrico ;

Folprecht, Gunnar ;

Van Laethem, Jean Luc ;

Lepage, Come ;

Emile, Jean-Francois ;

Laurent-Puig, Pierre .

JAMA ONCOLOGY, 2016, 2 (05) :643-652

[36] Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study [J].

Tougeron, David ;

Mouillet, Guillaume ;

Trouilloud, Isabelle ;

Lecomte, Thierry ;

Coriat, Romain ;

Aparicio, Thomas ;

Guetz, Gaetan Des ;

Lecaille, Cedric ;

Artru, Pascal ;

Sickersen, Gaelle ;

Cauchin, Estelle ;

Sefrioui, David ;

Boussaha, Tarek ;

Ferru, Aurelie ;

Matysiak-Budnik, Tamara ;

Silvain, Christine ;

Karayan-Tapon, Lucie ;

Pages, Jean-Christophe ;

Vernerey, Dewi ;

Bonnetain, Franck ;

Michel, Pierre ;

Taieb, Julien ;

Zaanan, Aziz .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (07)

[37] Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study [J].

Van Cutsem, E ;

Twelves, C ;

Cassidy, J ;

Allman, D ;

Bajetta, E ;

Boyer, M ;

Bugat, R ;

Findlay, M ;

Frings, S ;

Jahn, M ;

McKendrick, J ;

Osterwalder, B ;

Perez-Manga, G ;

Rosso, R ;

Rougier, P ;

Schmiegel, WH ;

Seitz, JF ;

Thompson, P ;

Vieitez, JM ;

Weitzel, C ;

Harper, P .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (21) :4097-4106

[38] Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3 [J].

Van Cutsem, Eric ;

Labianca, Roberto ;

Bodoky, Gyoery ;

Barone, Carlo ;

Aranda, Enrique ;

Nordlinger, Bernard ;

Topham, Claire ;

Tabernero, Josep ;

Andre, Thierry ;

Sobrero, Alberto F. ;

Mini, Enrico ;

Greil, Richard ;

Di Costanzo, Francesco ;

Collette, Laurence ;

Cisar, Laura ;

Zhang, Xiaoxi ;

Khayat, David ;

Bokemeyer, Carsten ;

Roth, Arnaud D. ;

Cunningham, David .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3117-3125

[39] A phase III randomised trial of LV5FU2+irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) [J].

Ychou, M. ;

Raoul, J. -L. ;

Douillard, J. -Y. ;

Gourgou-Bourgade, S. ;

Bugat, R. ;

Mineur, L. ;

Viret, F. ;

Becouarn, Y. ;

Bouche, O. ;

Gamelin, E. ;

Ducreux, M. ;

Conroy, T. ;

Seitz, J. -F. ;

Bedenne, L. ;

Kramar, A. .

ANNALS OF ONCOLOGY, 2009, 20 (04) :674-680

[40] Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses [J].

Yothers, Greg ;

O'Connell, Michael J. ;

Allegra, Carmen J. ;

Kuebler, J. Philip ;

Colangelo, Linda H. ;

Petrelli, Nicholas J. ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) :3768-3774

← 1 2 3 4 5 →